RCUS
Arcus Biosciences, Inc.stockNYSE
Market OpenNov 19, 2026 9:49:16 AM EST
15.72USD-0.286%(-0.04)61,738
RCUS Financials
In Q3 FY 2026 (ended ), Arcus Biosciences, Inc. (RCUS) reported revenue of $9M, net income of −$128M, operating cash flow of −$88M, and assets of $818M (filed ).
Loading financial flows…